Physical Activity Program and Nutrition Therapeutic Education During Treatment of Head and Neck Cancer Population (APANVADS)

September 6, 2016 updated by: University Hospital, Limoges

Feasibility Study: Physical Activity Program Associated Wtih Nutrition Therapeutic Education in Head and Neck Cancer Population Treating by Chemotherapy With or Without Radiotherapy.

The purpose of this study is to examine the feasibility of resistance training and physical functioning associated with nutrition therapeutic education in head and neck cancer patients, during their treatment (chemotherapy with or without radiotherapy).

Study Overview

Status

Terminated

Conditions

Intervention / Treatment

Detailed Description

The loss of muscle mass (i.e., sarcopenia) has been identified as a negative prognosis descriptor, disregarding the type of cancer. It is also a predictive descriptor for treatment-related toxicity. Therefore it appears crucial to save muscle mass of patients, following an adequate physical training together with a personalised diet program. The latter point is of major importance as malnutrition concerns 45% patients having head and neck cancer cancer, who stop physical activity due to extreme tiredness and decrease of quality of life. In the present project, we plan a physical activity program that would be adapted to each patient, accompanied by the rethought diet over a 3-month period. The adapted physical activity (APA) is constituted of two aerobic stages and one resistance training stage per a week. The evaluation will then proceed at three different moments, namely (i) at T0 i.e., beginning of the program, (ii) at 3 months i.e., when the program will be stopped, and (iii) at 6 months i.e., three months after the program stop. This evaluation will include the success rate, the level of satisfaction, the physiological parameters (VO2max, muscle mass and strength, BMI) and quality of life.

Study Type

Interventional

Enrollment (Actual)

10

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Limoges, France, 87042
        • CHU LIMOGES - Explorations Fonctionnelles Respiratoires
      • Limoges, France, 870
        • CHU LIMOGES - Oncologie

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age>18 years
  • Written informed consent provided before any study specific procedures
  • Consent to cooperate for clinical assessments
  • Affiliation to a social security regime or beneficiary of equivalent social protection
  • Performance status between 0 and 2
  • Squamous cell carcinoma of oral cavity, oropharynx or hypopharynx
  • Stage III - IV (T1-T4, N0-N3, M)(UICC 2002)
  • Indication of radiotherapy and chemotherapy post-operative or first-line metastatic chemotherapy or in inoperable condition
  • Ability to understand the nature, goal and study methodology

Exclusion Criteria:

  • Prior neoadjuvant chemotherapy
  • timed vital capacity< 70%
  • Presence of another severe pathology including:
  • severe or chronic cardiac, pulmonary, renal and/or hepatic insufficiencies
  • Cons-indication to physical activity practice, at discretion of the investigator
  • Patient under guardianship
  • Psychological, social, geographical, or familial reasons prohibiting physical activity and follow-up
  • Any other primary tumor during the last 5 years
  • Pregnant or nursing

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: APA
Patient with neck cancer and accepting the physical activity program .
A 3-month program for physical activity and diet education will be followed. An exercise specialist will supervise patients twice per week, during the first six weeks. They will also follow nutrition counselling and therapeutic education by a dietician once per week. During the last six weeks, they will just follow a guide for safe and appropriate exercise regimen. The dietician will call patient weekly during this final period.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
feasibility of the APA with a composite outcome measure
Time Frame: 3 months

The evaluation criteria for the PA program will be:

  • The success rate that will be reached if 80% of physical exercises will be performed by the patient, over the 3-month period,
  • The level of satisfaction that will be evaluated with questionnaires filled by the patient.
3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Evaluation of the personalised diet program and the therapeutic education with a composite outcome measure.
Time Frame: 3 months

The evaluation criteria for the personalised diet program and the therapeutic education will be:

  • The success rate that will be reached if 80% of requirements will be addressed by the patient,
  • The level of satisfaction that will be evaluated with questionnaires filled by the patient.
3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: FRANCOIS Vincent, MD, Limoges UH
  • Principal Investigator: Sabrina FALKOWSKI, MD, CHU LIMOGES - Oncologie

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

May 1, 2013

Primary Completion (Actual)

June 1, 2015

Study Completion (Actual)

June 1, 2015

Study Registration Dates

First Submitted

July 22, 2013

First Submitted That Met QC Criteria

July 25, 2013

First Posted (Estimate)

July 30, 2013

Study Record Updates

Last Update Posted (Estimate)

September 7, 2016

Last Update Submitted That Met QC Criteria

September 6, 2016

Last Verified

September 1, 2016

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • I12018 APANVADS

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Neck Cancer

Clinical Trials on APA

Subscribe